Don Egan

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Bristol-Myers Squibb (United States)(Current)

Don Egan is an author at Bristol-Myers Squibb (United States) specializing in ligand-based design, medicinal chemistry applications, and pharmacology.

Publications per year

2011–2013

Publications

Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)

Pratik Devasthale, Ying Wang, Wei Wang et al. · Journal of Medicinal Chemistry · 2013 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

7-Oxopyrrolopyridine-derived DPP4 inhibitors—mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site

Wei Wang, Pratik Devasthale, Aiying Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–2 of 2